EUVIMEDEUVIMED entdecken
Crossref

A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma

Zi-Xuan Guo, Yue-E Wu, Hai-Yan Shi, John van den Anker, Ping Liang, Ying Zheng, Xue-Wei Zhao, Rui Feng, Wei Zhao

Journal of Pharmaceutical and Biomedical Analysis · 2023-02 · 224 · 115159

DOI: 10.1016/j.jpba.2022.115159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023-02. Verfasst von Zi-Xuan Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Me…. Hauptthemen laut MEDLINE: Tyrosine Kinase Inhibitors, Protein Kinase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Shandong University, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, the use of targeted drugs such as tyrosine kinase inhibitors (TKIs) plays an important role in clinical therapy. As the number of approved TKIs continues to increase, existing analysis methods will not be able to meet the growing needs, and will hamper the development of therapeutic drug monitoring (TDM) of TKIs. Based on LC-MS/MS technology, this study tends to develop and validate a multi-component analysis method for simultaneous determination of the concentrations of 39 TKIs in plasma. Spiked plasma was blended with isotope labelled internal standards, and injected into the LC-MS/MS system after protein precipitation by acetonitrile. Chromatographic separation was achieved using an ODS-4 column with gradient elution of formic acid/water (1:1000; v/v) and acetonitrile. Analytes detection was conducted in positive ionisation mode using MRM. The total run time was 8 min. The method validation was conducted by assessing the following parameters: selectivity, linearity and the lower limit of qualification, accuracy and precision, stability, matrix effect and recovery. The concentrations of 39 TKIs showed good linearity within the range of their respective standard curves in plasma, the accuracy of all quality control samples ranged from 85.9% to 114.1%, and the precision was lower than 13.3%. The extraction recovery ranged from 92.6% to 114.7%, and the matrix effect of plasma was lower than 11.3%. This new method was successfully developed, can be used for the determination of drug concentrations in multiple patients with different kinds of TKIs, and will therefore be suitable for TDM of 39 TKIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tyrosine Kinase InhibitorsProtein Kinase InhibitorsHumansChromatography, LiquidTandem Mass SpectrometryChromatography, High Pressure LiquidReproducibility of Results

Stichwörter der Autor:innen

LC-MS/MSMulti-component analysisPlasma drug concentrationTyrosine kinase inhibitor

Substanzen

Tyrosine Kinase InhibitorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China; Department of Pharmacy, Chi…
  • Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Devel…
  • Division of Clinical Pharmacology, Children's National Hospital, Washington DC, USA; Departments of Pediatrics, Pharmacology & Physiology, Genomics & Precision Medicine, the George Washington University School of Medici…
  • Department of Pharmacy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Pharmacy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Electronic address: fengrui-125@163.com.

Förderung

  • Shandong University
  • National Key Research and Development Program of China

Zitieren

APA

Guo, Z. X., Wu, Y. E., Shi, H. Y., van den Anker, J., Liang, P., Zheng, Y., Zhao, X. W., Feng, R., & Zhao, W. (2023). A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 224, 115159. https://doi.org/10.1016/j.jpba.2022.115159

Vancouver

Guo ZX, Wu YE, Shi HY, van den Anker J, Liang P, Zheng Y, et al. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 2023;224:115159. doi:10.1016/j.jpba.2022.115159

BibTeX
@article{Guo2023,
  author = {Guo, Zi-Xuan and Wu, Yue-E and Shi, Hai-Yan and van den Anker, John and Liang, Ping and Zheng, Ying and Zhao, Xue-Wei and Feng, Rui and Zhao, Wei},
  title = {A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2023},
  volume = {224},
  pages = {115159},
  doi = {10.1016/j.jpba.2022.115159}
}
Kostenlos starten →